Cargando…
Methylphenidate for Attention-Deficit and Hyperactivity Disorder in Adult Patients With Substance Use Disorders: Good Clinical Practice
Attention-deficit and hyperactivity disorder (ADHD) is a widespread neurodevelopmental disorder in children and adolescents, persisting into adulthood in a majority of them. ADHD and substance use disorders (SUDs) commonly co-occur in the clinical adult population. The higher-than-normal prevalence...
Autores principales: | Chamakalayil, Sunsha, Strasser, Johannes, Vogel, Marc, Brand, Serge, Walter, Marc, Dürsteler, Kenneth M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870681/ https://www.ncbi.nlm.nih.gov/pubmed/33574770 http://dx.doi.org/10.3389/fpsyt.2020.540837 |
Ejemplares similares
-
New Insights on the Effects of Methylphenidate in Attention Deficit Hyperactivity Disorder
por: Pitzianti, Maria Bernarda, et al.
Publicado: (2020) -
Case report: Methylphenidate improved chronic pain in an adult patient with attention deficit hyperactivity disorder
por: Zain, Ekachaeryanti, et al.
Publicado: (2023) -
Co-occurring Mental Disorders in Transitional Aged Youth With Substance Use Disorders – A Narrative Review
por: Köck, Patrick, et al.
Publicado: (2022) -
Methylphenidate use in children with attention deficit hyperactivity disorder
por: Machado, Felipe Salles Neves, et al.
Publicado: (2015) -
Psychoactive substance use in patients diagnosed with attention-deficit/hyperactivity disorder: an exploratory study
por: Więckiewicz, Gniewko, et al.
Publicado: (2023)